Cargando...
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
INTRODUCTION: The introduction of recombinant human erythropoietin revolutionized the management of anemia in patients with chronic kidney disease (CKD). In order to circumvent costly recombinant DNA technology, synthetic chemistry techniques were used to manufacture peginesatide, a synthetic peptid...
Gardado en:
| Publicado en: | Expert Opin Drug Saf |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286458/ https://ncbi.nlm.nih.gov/pubmed/27551882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2016.1218467 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|